Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization

Area of Science:

• Immunology
• Geriatric Medicine
• Public Health

Background:

• Tetanus and diphtheria disproportionately affect individuals over 60 in the U.S.
• Elderly populations often exhibit suboptimal antibody levels against preventable infectious diseases.

Purpose of the Study:

• To assess the prevalence of protective tetanus and diphtheria antibody levels in elderly individuals.
• To evaluate the immunogenicity and safety of a two-dose tetanus-diphtheria (Td) toxoid vaccination regimen in this demographic.

Main Methods:

• Sera from 69 elderly individuals (mean age 80) were analyzed for tetanus and diphtheria antibody titers.
• A prospective study involved 27 elderly volunteers receiving two doses of Td toxoid, 7 months apart.
• Antibody levels were measured before vaccination, after the first dose, and after the second dose.

Main Results:

• Initially, only 51% and 59% of participants had protective tetanus and diphtheria antibody levels, respectively.
• Following the first Td toxoid dose, protection increased to 42% for tetanus and 88% for diphtheria.
• After the second dose, all participants achieved protective antibody levels against both diseases.
• No significant adverse events were reported after either vaccination.

Conclusions:

• A significant proportion of the elderly population is vulnerable to tetanus and diphtheria due to insufficient antibody levels.
• Two doses of Td toxoid are highly effective in conferring protective immunity against tetanus and diphtheria in older adults.
• Td toxoid vaccination is a safe and effective strategy to enhance immunity in the elderly population.